Skip Navigation


Brain Advance Access originally published online on October 3, 2006
Brain 2006 129(12):3238-3248; doi:10.1093/brain/awl261
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/12/3238    most recent
awl261v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bühnemann, C.
Right arrow Articles by Dihné, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bühnemann, C.
Right arrow Articles by Dihné, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats

Claudia Bühnemann1,{dagger}, Andreas Scholz2,{dagger}, Christian Bernreuther3, Christoph Y. Malik2, Holger Braun1, Melitta Schachner3, Klaus G. Reymann1,{dagger} and Marcel Dihné4,{dagger}

1 Leibniz Institut für Neurobiologie (IfN), Neuropharmakologie Magdeburg 2 Justus-Liebig Universität, Institut für Physiologie Giessen 3 Zentrum für Molekulare Neurobiologie Hamburg, Universität Hamburg Düsseldorf, Germany 4 Heinrich-Heine Universität, Neurologische Klinik Düsseldorf, Germany

Correspondence to: Claudia Bühnemann, Neuropharmacology, Leibniz Institute for Neurobiology, Brenneckestrasse 6, D-39118 Magdeburg, Germany E-mail: claudia.buehnemann{at}ifn-magdeburg.de

Stroke represents one of the leading causes of death and disability in Western countries, but despite intense research, only few options exist for the treatment of stroke-related infarction of brain tissue. In experimental stroke, cell therapy can partly reverse some behavioural deficits. However, the underlying mechanisms have remained unknown as most studies revealed only little, if any, evidence for neuronal replacement and the observed behavioural improvements appeared to be related rather to a graft-derived induction of a positive response in the remaining host tissue than to cell replacement by the graft itself. The present study was performed to test a murine embryonic stem cell (ESC)-based approach in rats subjected to endothelin-induced middle cerebral artery occlusion. Efficacy of cell therapy regarding graft survival, neuronal yield and diversity, and electrophysiological features of the grafted cells were tested after transplanting ESC-derived neural precursors into the infarct core and periphery of adult rats. Here, we show that grafted cells can survive, albeit not entirely, most probably as a consequence of an ongoing immune response, within the infarct core for up to 12 weeks after transplantation and that they differentiate with high yield into immunohistochemically mature glial cells and neurons of diverse neurotransmitter-subtypes. Most importantly, transplanted cells demonstrate characteristics of electrophysiologically functional neurons with voltage-gated sodium currents that enable these cells to fire action potentials. Additionally, during the first 7 weeks after transplantation we observed spontaneous excitatory post-synaptic currents in graft-derived cells indicating synaptic input. Thus, our observations show that ESC-based regenerative approaches may be successful in an acutely necrotic cellular environment.

Key Words: stem cells; brain ischaemia; transplantation; differentiation; electrophysiology

Abbreviations: AP, action potential; EGFP, enhanced green fluorescent protein; EPSP, excitatory post-synaptic potentials; ESC, embryonic stem cell; GFAP, glial fibrillary acidic protein; MCAO, middle cerebral artery occlusion

.

Received February 27, 2006. Revised August 9, 2006. Accepted August 11, 2006.


{dagger}These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
M. Bacigaluppi, S. Pluchino, L. P. Jametti, E. Kilic, U. Kilic, G. Salani, E. Brambilla, M. J. West, G. Comi, G. Martino, et al.
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Brain, August 1, 2009; 132(8): 2239 - 2251.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.